Edwards Lifesciences Corporation

NYSE

Healthcare

Medical - Devices

Irvine, CA, US15,800 employeesedwards.com

$80.85

-0.41(-0.50%)

Mkt Cap $47.0B

$67.07

$87.18

52-Week Range

At A Glance

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally.

Revenue is primarily driven by United States Segment (58.7%) and Europe Segment (24.3%).

Most recently: , including Exhibit 99.1, shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended. Item 9.01. Financial Statements and (2026-02-10).

$47.0B

Market Cap

$6.1B

Revenue

$1.1B

Net Income

Employees15,800

Fundamentals

How The Business Makes Money

Revenue by Segment

United States Segment58.7%($9.7B)

Europe Segment24.3%($4.0B)

Rest Of World Segment10.6%($1.8B)

Japan Segment6.3%($1.0B)

Activity

What Changed Recently

Financial Results

Feb 9, 2026

, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended. Item 9.01. Financial Statements and

Regulation FD

Jan 11, 2026

, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),

Peer Companies

Company	Price	Change	Market Cap	P/E
BDXBecton, Dickinson and Com...	$154.72	-1.03%	$56.1B	25.3
CAHCardinal Health, Inc.	$214.03	+0.95%	$50.4B	29.2
ARGXargenx SE	$745.24	+0.28%	$46.1B	37.1
HLNHaleon plc	$9.95	-0.25%	$44.3B	21.8
ALCAlcon Inc.	$74.49	-1.35%	$36.3B	37.0
AAgilent Technologies, Inc...	$115.40	+0.75%	$32.6B	24.6
VEEVVeeva Systems Inc.	$173.73	+0.57%	$28.6B	33.5
DXCMDexCom, Inc.	$62.22	-0.24%	$24.3B	30.5

Analyst View

Company Profile

CIK0001099800

ISINUS28176E1082

CUSIP28176E108

Phone949 250 2500

AddressOne Edwards Way, Irvine, CA, 92614, US

SEC EDGAR